MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 40 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,761 | -60.8% | 30,001 | -0.8% | 0.00% | – |
| Q2 2023 | $45,365 | -12.1% | 30,243 | +0.8% | 0.00% | – |
| Q1 2023 | $51,602 | +18.8% | 30,001 | -20.6% | 0.00% | – |
| Q4 2022 | $43,428 | -56.1% | 37,764 | -0.6% | 0.00% | – |
| Q3 2022 | $99,000 | +52.3% | 38,002 | +26.7% | 0.00% | – |
| Q2 2022 | $65,000 | -53.9% | 30,001 | -0.6% | 0.00% | – |
| Q1 2022 | $141,000 | -24.6% | 30,171 | -2.2% | 0.00% | – |
| Q4 2021 | $187,000 | +73.1% | 30,835 | +105.6% | 0.00% | – |
| Q3 2021 | $108,000 | +237.5% | 15,001 | +199.1% | 0.00% | – |
| Q2 2021 | $32,000 | – | 5,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |